megestrol acetate has been researched along with norethynodrel in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Hyder, SM; Murthy, L; Stancel, GM | 1 |
Swyer, GI | 1 |
Applezweig, N | 1 |
Fekete, G | 1 |
7 other study(ies) available for megestrol acetate and norethynodrel
Article | Year |
---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Thromboembolic disease and the steroidal content of oral contraceptives.
Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Megestrol Acetate; Mestranol; Norethynodrel; Pulmonary Embolism; Thromboembolism; Thrombosis; Vascular Diseases | 1970 |
Steroids.
Topics: Adrenal Cortex Hormones; Africa; Americas; Asia; Biology; Chlormadinone Acetate; Contraception; Contraceptives, Oral; Developed Countries; Developing Countries; Dimethisterone; Economics; Endocrine System; Estradiol; Ethynodiol Diacetate; Europe; Europe, Eastern; Family Planning Services; Germany, West; Hormones; Italy; Latin America; Medroxyprogesterone Acetate; Megestrol Acetate; Mestranol; Mexico; Netherlands; Norethindrone; Norethynodrel; Norgestrel; North America; Physiology; Progesterone; Progestins; Research; Switzerland; Technology; Testosterone; United Kingdom; United States | 1969 |
Chemistry, pharmacology and clinical pharmacology of oral contraceptives.
Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Ethynodiol Diacetate; Family Planning Services; Lynestrenol; Medroxyprogesterone Acetate; Megestrol Acetate; Norethindrone; Norethynodrel | 1968 |